Blood Sciences Test

Neuronal Antibodies



Special Instructions

Minimum sample volume: 3 ml

Test Usage

Paraneoplastic disorders are characterised by the presence of neuronal autoantibodies in patient serum. The detection of these autoantibodies is useful for the clinician, as it suggests the presence of an underlying tumour. Tumours that have been known to initiate paraneoplastic disorders include small cell lung carcinoma (SCLC), thymoma, neuroblastoma, and breast, ovarian, and testicular cancers. The following autoantibodies are found in paraneoplastic syndromes:

Turnaround time



Referred Test

Assayed By

This investigation is performed at the Immunology Department, Churchill Hospital, Headington, Oxford, OX3 7LJ

Specimen Labelling Procedure